Hookworm larvae (DrugBank: -)
1 disease| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 13 | 多発性硬化症／視神経脊髄炎 | 2 |
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01470521 (ClinicalTrials.gov) | December 2011 | 9/11/2011 | Worms for Immune Regulation of Multiple Sclerosis | Worms for Immune Regulation of Multiple Sclerosis (WIRMS) | Multiple Sclerosis, Relapsing-Remitting | Biological: Hookworm larvae;Biological: Placebo | University of Nottingham | National Multiple Sclerosis Society | Completed | 18 Years | 65 Years | Both | 72 | Phase 2 | United Kingdom |
| 2 | NCT00630383 (ClinicalTrials.gov) | February 2008 | 27/2/2008 | Immunoregulation by Controlled Parasite Exposure in Multiple Sclerosis. | Immunoregulation by Controlled Parasite Exposure in Multiple Sclerosis. | Multiple Sclerosis | Biological: Live Hookworm Larvae;Other: Histamine | University of Nottingham | NULL | Withdrawn | 18 Years | 60 Years | Both | 0 | Phase 2 | United Kingdom |